Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals | -5.710% | 1.153% | -3.748% | -19.822% | -44.384% | -8.831% | -32.457% |
Acceleron Pharma Inc. | - | - | - | - | - | - | - |
Agios Pharmaceuticals Inc. | -3.110% | 1.307% | 21.094% | 33.621% | 50.485% | -32.211% | -31.628% |
Alnylam Pharmace. | -1.090% | 5.228% | -1.321% | -25.629% | -19.831% | 29.294% | 115.326% |
Amicus Therapeutics Inc. | -2.650% | - | - | - | - | - | - |
Arena Pharmaceuticals Inc | - | - | - | - | - | - | - |
Arrowhead Pharmaceuticals Inc. | -1.030% | 10.608% | -0.929% | -36.181% | -16.690% | -57.017% | 43.504% |
Bluebird Bio Inc. | 20.600% | 7.624% | -15.845% | -77.181% | -27.525% | -96.391% | - |
Blueprint Medicines Corp | -0.200% | 18.169% | 19.934% | 103.213% | 22.667% | 30.952% | - |
Catalent Inc. | 0.340% | 0.459% | 0.632% | 63.484% | 27.573% | -40.610% | 26.957% |
Charles River Labs Intl | 0.550% | 1.155% | -6.769% | 26.920% | 2.817% | -22.340% | - |
Emergent Biosolutions Inc. | -1.270% | 132.607% | 92.639% | -50.374% | 84.425% | -91.892% | -90.136% |
Exelixis Inc. | 1.250% | -7.458% | -4.728% | 17.562% | -6.993% | -1.405% | 10.382% |
Fibrogen Inc. | 1.750% | 11.681% | -29.567% | -93.478% | 22.849% | -93.647% | - |
Genomic Health | -2.270% | - | - | - | - | - | - |
Global Blood Therapeutics Inc | - | - | - | - | - | - | - |
Halozyme Therapeutics Inc. | 2.920% | 6.981% | 6.282% | 42.109% | 15.451% | -0.077% | - |
Immunomedics Inc. | - | - | - | - | - | - | - |
Invitae Corp | -78.840% | - | - | - | - | - | - |
Ionis Pharmaceuticals Inc. | -1.740% | -3.312% | -3.983% | 16.818% | -18.174% | 24.401% | -38.374% |
Iovance Biotherapeutics Inc. | -0.360% | 12.908% | 3.573% | 93.857% | 59.644% | -46.822% | - |
Ironwood Pharmaceuticals | 0.670% | 2.759% | 2.055% | -22.798% | -26.961% | -18.132% | - |
Ligand Pharmaceuticals | 8.760% | 12.782% | 2.041% | 6.383% | 15.385% | -28.537% | -32.127% |
Loxo Oncology Inc | - | - | - | - | - | - | - |
Medicines Co. | - | - | - | - | - | - | - |